ダウンロード数: 512
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
62_7_341.pdf | 732.74 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | 宇都宮, 紀明 | ja |
dc.contributor.author | 松本, 敬優 | ja |
dc.contributor.author | 常森, 寛行 | ja |
dc.contributor.author | 六車, 光英 | ja |
dc.contributor.author | 川喜田, 睦司 | ja |
dc.contributor.author | 上山, 裕樹 | ja |
dc.contributor.author | 金丸, 聰淳 | ja |
dc.contributor.author | 伊藤, 哲之 | ja |
dc.contributor.author | 塚崎, 秀樹 | ja |
dc.contributor.author | 白波瀬, 敏明 | ja |
dc.contributor.author | 高橋, 毅 | ja |
dc.contributor.alternative | Utsunomiya, Noriaki | en |
dc.contributor.alternative | Matsumoto, Keiyu | en |
dc.contributor.alternative | Tsunemori, Hiroyuki | en |
dc.contributor.alternative | Muguruma, Koei | en |
dc.contributor.alternative | Kawakita, Mutsushi | en |
dc.contributor.alternative | Kamiyama, Yuki | en |
dc.contributor.alternative | Kanamaru, Sojun | en |
dc.contributor.alternative | Ito, Noriyuki | en |
dc.contributor.alternative | Tsukazaki, Hideki | en |
dc.contributor.alternative | Shirahase, Toshiaki | en |
dc.contributor.alternative | Takahashi, Takeshi | en |
dc.contributor.alternative | 兵庫UB(Unstable Bladder)研究会 | ja |
dc.contributor.alternative | Hyogo UB (Unstable Bladder) Study Group | en |
dc.date.accessioned | 2016-08-18T08:21:58Z | - |
dc.date.available | 2016-08-18T08:21:58Z | - |
dc.date.issued | 2016-07-31 | - |
dc.identifier.issn | 0018-1994 | - |
dc.identifier.uri | http://hdl.handle.net/2433/216315 | - |
dc.description.abstract | We compared the efficacy of naftopidil monotherapy with combination therapy using tamsulosin hydrochloride and solifenacin succinate in the treatment of lower urinary tract symptoms (LUTS) with overactive bladder (OAB) secondary to benign prostatic hyperplasia (BPH). Thirty one patients were enrolled in a randomized crossover study. Fourteen patients were initially prescribed naftopidil 75 mg (N) for 8 weeks, followed by tamsulosin 0.2 mg and solifenacin 5 mg (TS) for 8 weeks (group N) ; another 17 were initially prescribed TS, followed by N (group TS). The efficacy variables were the changes in international prostate symptom score (I-PSS), quality of life (QOL) score, overative bladder symptom score (OABSS), and post-void residual (PVR) urine volume. After the study, a questionnaire survey was carried out about the choice of treatment. After treatment with each agent, total I-PSS, storage symptom score, QOL score and OABSS except for the daytime frequency were significantly improved from baseline. PVR was significantly increased after TS treatment. There were no significant differences between the two treatments except for PVR. As a result of the questionnaire survey, 13 patients chose N and 17 chose TS. In conclusion, N monotherapy can be expected to have an equal effect in the treatment of LUTS with OAB secondary to BPH in comparison with TS combination therapy. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | jpn | - |
dc.publisher | 泌尿器科紀要刊行会 | ja |
dc.rights | 許諾条件により本文は2017/08/01に公開 | ja |
dc.subject | OAB | en |
dc.subject | BPH | en |
dc.subject | Naftopidil | en |
dc.subject.ndc | 494.9 | - |
dc.title | 過活動膀胱を有する前立腺肥大症患者に対する薬物治療の臨床的検討 : クロスオーバー法を用いた比較検討 | ja |
dc.title.alternative | A Crossover Comparison Study on Lower Urinary Tract Symptoms with Overactive Bladder Secondary to Benign Prostatic Hyperplasia: Naftopidil versus Tamsulosin with Solifenacin | en |
dc.type | departmental bulletin paper | - |
dc.type.niitype | Departmental Bulletin Paper | - |
dc.identifier.ncid | AN00208315 | - |
dc.identifier.jtitle | 泌尿器科紀要 | ja |
dc.identifier.volume | 62 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | 341 | - |
dc.identifier.epage | 347 | - |
dc.textversion | publisher | - |
dc.sortkey | 01 | - |
dc.address | 神戸市立医療センター中央市民病院泌尿器科・現: 京都大学医学部泌尿器科 | ja |
dc.address | 神戸市立医療センター中央市民病院泌尿器科・現: 国立病院機構京都医療センター泌尿器科 | ja |
dc.address | 神戸市立医療センター中央市民病院泌尿器科・現: 香川大学医学部泌尿器科 | ja |
dc.address | 神戸市立医療センター中央市民病院泌尿器科・現: 関西医科大学附属滝井病院腎泌尿器外科 | ja |
dc.address | 神戸市立医療センター中央市民病院泌尿器科 | ja |
dc.address | 西神戸医療センター泌尿器科・現: 日本赤十字社和歌山医療センター泌尿器科 | ja |
dc.address | 西神戸医療センター泌尿器科 | ja |
dc.address | 西神戸医療センター泌尿器科 | ja |
dc.address | 国立病院機構姫路医療センター泌尿器科・現: ツカザキ病院泌尿器科 | ja |
dc.address | 国立病院機構姫路医療センター泌尿器科・現: 公立豊岡病院組合立豊岡病院泌尿器科 | ja |
dc.address | 兵庫県立塚口病院泌尿器科・現: 大阪赤十字病院泌尿器科 | ja |
dc.address.alternative | The Department of Urology, Kobe City Medical Center General Hospital | en |
dc.address.alternative | The Department of Urology, Kobe City Medical Center General Hospital | en |
dc.address.alternative | The Department of Urology, Kobe City Medical Center General Hospital | en |
dc.address.alternative | The Department of Urology, Kobe City Medical Center General Hospital | en |
dc.address.alternative | The Department of Urology, Kobe City Medical Center General Hospital | en |
dc.address.alternative | The Department of Urology, Nishi-Kobe Medical Center | en |
dc.address.alternative | The Department of Urology, Nishi-Kobe Medical Center | en |
dc.address.alternative | The Department of Urology, Nishi-Kobe Medical Center | en |
dc.address.alternative | The Department of Urology, National Hospital Organization Himeji Medical Center | en |
dc.address.alternative | The Department of Urology, National Hospital Organization Himeji Medical Center | en |
dc.address.alternative | The Department of Urology, Hyogo Prefectural Tsukaguchi Hospita | en |
dc.identifier.pmid | 27569351 | - |
dc.identifier.selfDOI | 10.14989/ActaUrolJap_62_7_341 | - |
dcterms.accessRights | open access | - |
datacite.date.available | 2017-08-01 | - |
dc.identifier.pissn | 0018-1994 | - |
dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
出現コレクション: | Vol.62 No.7 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。